A Vienna-based biotech startup developing a targeted breast cancer drug and a technology platform that precisely links antibodies and cell toxins to improve cancer treatment efficacy and tolerability.
Industries
Frequently Asked Questions
Where is Valanx located?
Valanx is located in Vienna, Austria.
What industries does Valanx operate in?
Valanx operates in the following industries: biotech, oncology, drug development.
Who are the founders of Valanx?
The founders of Valanx are: Michael Lukesch, Georg Altenbacher.
What is the core technology developed by Valanx?
Valanx offers a patented site-specific protein conjugation platform that uses genetic code expansion to incorporate synthetic amino acids into proteins at precise locations.
How does Valanx ensure the homogeneity of protein conjugates?
Valanx achieves homogeneity by controlling the exact site and number of conjugations on a protein, resulting in a defined molecular composition that improves safety and efficacy.
What are the advantages of using Valanx for vaccine manufacturing?
The Valanx platform provides ready-to-conjugate carrier proteins that use fast click chemistry to enable rapid and high-yield production of conjugate vaccines without the need for complex catalysts.
Which expression systems are compatible with the Valanx platform?
The technology is designed for scalability and can be used with standard industrial host systems such as E. coli and CHO cells.
How does Valanx simplify the conjugation process for developers?
Valanx simplifies the process by requiring no external catalysts or enzymes for the reaction, allowing developers to simply purify the protein and perform the conjugation.
What primary applications does the Valanx technology support?
The technology supports the development of antibody-drug conjugates, vaccines, diagnostics, and functionalized surfaces for biosensors.